Wulfrath
Germany
20
2025-10-23
The entities that hold a legal rights for patent applications filed by inventor Trautwein Mark:
Mark Trautwein from Wulfrath, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
MEDICAL USE OF CCR8 ANTIBODIES AND DOSING SCHEDULE
#2 | 2024-12-05CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
#3 | 2024-11-14CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
#4 | 2024-11-07ANTI-CECAM6 ANTIBODIES WITH REDUCED SIDE-EFFECTS
#5 | 2024-09-26INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
#6 | 2024-04-18INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
#7 | 2023-08-10SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION
#8 | 2022-11-17Methods of treatment using CCR8 antibodies
#9 | 2022-03-24Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies
#10 | 2022-01-13PHARMACEUTICAL COMBINATION OF ANTI-CEACAM6 AND EITHER ANTI-PD-1 OR ANTI-PD-L1 ANTIBODIES FOR THE TREATMENT OF CANCER
#11 | 2019-10-03RADIO-PHARMACEUTICAL COMPLEXES
#12 | 2016-11-03Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
#13 | 2016-01-14PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF
#14 | 2014-10-30Anti-FGFR2 Antibodies and Uses Thereof
#15 | 2014-07-03Relaxin fusion polypeptides and uses thereof
#16 | 2014-05-22Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
#17 | 2013-10-17Neutralizing prolactin receptor antibodies and their therapeutic use
#18 | 2013-07-04NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
#19 | 2013-05-23Neutralizing prolactin receptor antibodies and their therapeutic use
#20 | 2013-01-24NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
52400 ⎘